The Medical Imaging Arms market is primarily divided by application into diagnostic, therapeutic and research segments. Diagnostic arms, which integrate X‑ray, CT, MRI and ultrasound detectors, dominate the market, accounting for roughly 55 % of total revenue. Their prevalence stems from hospitals’ need for high‑throughput imaging stations and the growing demand for early disease detection across aging populations. Therapeutic arms, representing about 30 % of the market, are engineered to support image‑guided interventions such as radiation therapy, interventional radiology and minimally invasive surgeries; the segment benefits from rising oncology cases and the shift toward precision treatment. Research arms, contributing the remaining 15 %, are specialized for pre‑clinical and translational studies, often featuring modular designs and customizable detector arrays. Although smaller in absolute terms, this segment drives innovation that subsequently diffuses into diagnostic and therapeutic arms. Collectively, these application categories form the core of the Medical Imaging Arms segmentation and determine the allocation of R&D spend, pricing strategies and geographic expansion.